Developing hypertension guidelines: An evolving process

American Journal of Hypertension

Volumn 27, Issue 6, 2014, Pages 765-772

  Kotchen, Theodore A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

blood pressure; clinical guidelines; evaluation and treatment of hypertensions; hypertension; JNC

Indexed keywords

CHOLESTEROL; ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COMPARATIVE STUDY; DIASTOLIC BLOOD PRESSURE; HEALTH EDUCATION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MEDICAL SOCIETY; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; SECONDARY PREVENTION; SYSTOLIC BLOOD PRESSURE; CANADA; EUROPE; EVIDENCE BASED MEDICINE; STANDARDS; TREATMENT OUTCOME; UNITED STATES;

AMERICAN HEART ASSOCIATION; ANTIHYPERTENSIVE AGENTS; CANADA; EUROPE; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HUMANS; HYPERTENSION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; TREATMENT OUTCOME; UNITED STATES;

EID: 84900856991     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt298     Document Type: Article

References (62)

1. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: a cooperative study. JAMA 1977; 237:255-261.
2. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1980 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1980; 140:1280-1285.
3. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1984; 144:1045-1057.
4. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988; 148:1023-1038.
5. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure ( JNC V). Arch Intern Med 1993; 153:154-183.
6. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
7. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The seventh report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289:2560-2572.
8. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: II Results in patients with diastolic blood pressures averaging 90 through 114 mmHg. JAMA 1970; 213- 1143-1152.
9. Hypertension Detection and Follow-up Program Cooperative. Five-year findings of the Hypertension Detection and Follow-up Program. JAMA 1979; 242:2562-2577.
10. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: I Results in patients with diastolic blood pressures averaging 115-129 mmHg. JAMA 1967; 202:1028-1034.
11. Hypertension Detection and Follow-up Program Cooperative Group. The effect of treatment on mortality in "mild" hypertension. N Engl J Med 1983; 307:976-980.
12. Australian Therapeutic Trial in Mild Hypertension: Report by the Management Committee. Lancet 1980; 1:1261-1267.
13. Smith WMcF. Treatment of mild hypertension: Results of a ten-year intervention trial. US Public Health Service Hospitals Cooperative Study Group. Circulation Res 1977; 40 (Suppl I):98-105.
14. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results. JAMA 1982; 248:1465-1477.
15. MacMahon SW, Cutler JA, Furberg CD, Payne GH. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: A review of randomized clinical trials. Prog Cardiovasc Dis 1986; 29 (Suppl):99-118.
16. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet 1987; 1:581-583.
17. Working Group on Hypertension in the Elderly. Statement on hypertension in the elderly. JAMA 1986; 256:70-74.
18. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265:3255-3264.
19. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304:405-412.
20. MacMahon S, Rodgers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens 1993:15: 967-978.
21. Du X, Cruickshank K, McNamee R, Saraee M, Sourbutts J, Summers A, Roberets N, Walton E, Holmes J. Case-control study of stroke and the quality of hypertension control in northwest England. BMJ 1997; 314:272-276.
22. The Modification of Diet in Renal Disease Study Group. Achievement and safety of a low blood pressure goal in chronic renal disease. Hypertension 1997; 29:641-650.
23. Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MH, Hennen J. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997; 157:99-104.
24. Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JZ, Flack JM, Schoenberger JA, McDonald R, Lewis CE, Liebson PR, for the Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study: final results. JAMA 1993; 270:713-724.
25. American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes Care 2003; 26 (Suppl 1):S80-S82.
26. National Kidney Foundation Guideline. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002; 39 (Suppl 2):S1-S246.
27. Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL Jr, Kaplan NM, O'Connor CM, O'Gara PT, Oparil S for the American Heart Association Council for High Blood Pressure Research: American Heart Association Council on Clinical Cardiology: American Heart Association Council on Epidemiology and Prevention. Treatment of hypertension in the prevention and management of ischemic heart disease: scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007;115:2761-2788.
28. Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH, Hall WD, Jones WE, Kountz DS, Lea JP, Nasser S, Nesbitt SD, Saunders E, Scisney-Matlock M, Jamerson KA. Management of high blood pressure in blacks: an update of the Internal Society on Hypertension in Blacks-consensus statement. Hypertension 2010; 56:780-800.
29. Wright JT, Agodoa LY, Appel L, Cushman WC, Taylor AL, Obegdegbe GG, Osei K, Reed J. New recommendations for treating hypertension in black patients: evidence and/or consensus? Hypertension 2010; 56:801-803.
30. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, Ferdinand KC, Forsiea MA, Frishman WH, Jaigobin C, Kostis JB, Mancia G, Oparil S, Ortiz E, Resin E, Rich MW, Schocken DD, Weber MA, Wesley DJ. ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2011; 123:2434-2506.
31. WHO Expert Committee: Arterial hypertension. Technical Report Series No. 628 Geneva. World Health Organization, 1978.
32. Guidelines Sub-Committee. 1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting, J Hypertension 1993; 11:905-918.
33. Guidelines Sub-Committee. 1999 World Health Organization/International Society of Hypertension guidelines for the management of hypertension, J Hypertension 1999; 17:151-183.
34. Guidelines Committee. 2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of hypertension. I Hypertension 2003; 21:1011-1053.
35. Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension. European Heart J 2007; 28:1462-1536.
36. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burniesr M, Caulfield MI, Cifkova R, Clement D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen S, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HAJ, van Zwieten PA, Viigimaa M, Zanchetti A. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document, J Hypertension 2009; 27:2121-2158.
37. Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESH/.ESC guidelines for the management of arterial hypertension. European Heart J 2013; 34:2159-2219.
38. Zarnke KB, Campbell NR, McAlister FA, Levine M; Canadian Hypertension Recommendations Working Group. A novel process for updating recommendations for managing hypertension: rationale and methods. Can J Cardiol 2000;16:1094-1102.
39. Canadian Hypertension Education Program. The 2013 Canadian Hypertension Education (CHEP) recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 2013; 29:528-542.
40. Swales JD. Guidelines on guidelines. J Hypertension 1993; 11:899-903.
41. Jennings GLR, Touyz RM. Hypertension guidelines: more challenges highlighted by Europe. Hypertension 2013; 62:660-665.
42. Lenzer J, Hoffman J, Furberg C, Ioannidis J. Guideline Review Panel Working Group. Ensuring the integrity of clinical practice guidelines: a tool for protecting patients. 10.1136/bmj.f5535.
43. Weber MA. Hypertension guidelines: a major reappraisal critically examines the available evidence, J Clin Hyperten 2012; 12:229-236.
44. Institute of Medicine. Clinical practice guidelines we can trust, March 2011.
45. Institute of Medicine. Finding what works in health care: standards for systematic reviews, March 2011.
46. Gibbons GH, Shurin SB, Mensah GA, Lauer MS. Refocusing the agenda on cardiovascular guidelines: An announcement from the National Heart, Lung, and Blood Institute. Circulation 2013; 128:1713-1715.
47. Gibbons GH, Harold JG, Jessup M, Robertson RM, Oetgen W The next steps in developing clinical practice guidelines for prevention. Circulation 2013; 128:1716-1717.
48. Go AS, Bauman MA, King SMC, Fonarow GC, Lawrence W Willams KA, Sanchez E. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension 2013. DOI: 10.1161/HYP.0000000000000003.
49. http://my.americanheart.org/professional/ScienceNews/Clincial-Practice- Guidelines-for-Prevention-UCM-457211-Article.jsp. Accessed Dec. 10, 2013.
50. American Society of Hypertension and the International Society of Hypertension. Clinical practice guidelines for the management of hypertension in the community, J Clin Hypertens DOI: 10.1111/jch.12237.
51. Panel members appointed to the Eighth Joint National Committee (JNC 8). 2014 Evidence-based guideline for the management of high blood pressure in adults. JAMA DOI: 10.1001/jama.2013.284427.
52. Tanner L. Panel shifts blood pressure goal. Milwaukee Journal Sentinel, Dec 19, 2013; p3A.
53. Thompson D. New blood pressure guidelines. WebMD. http://www.webmd.com/ hypertension-high-blood-pressure/news/20131218/new-blood-pressure-guidelines- raise-the-bar-for-taking-medications. Accessed December 20, 2013.
54. Wright JT, Fine LJ, Lackland DT, Ogedegbe G, Himmelfarb CRD. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view. Ann Int Med 2014, in press.
55. CDC. Achievement in public health, 1900- 1999: decline in deaths from heart disease and stroke-United States, 1900-1999. MMWR 1999; 48: 649- 656. Heart disease and stroke statistics-2013 update. Circulation 2013; 127: e6-e245.
56. Kotchen TA. Historical trends and milestones in hypertension research: a model of the process of translational research. Hypertension 2011; 58:522-538.
57. Yoon SS, Burt V, Louis T, Carroll MD. Hypertension among adults in the United States, 2009-2010. http://www.cdc.gov/nchs/data/data-briefs/dbl07.htm. Accessed 10 February 2014.
58. Hill MN, Levine DM, Whelton PK Awareness, use, and impact of the 1984 Joint National Committee consensus report on high blood pressure. Am J Public Health 1988; 78:1190-1194.
59. Lenfant C. Clinical research to clinical practice: lost in translation? N Engl J Med 2003; 349:868-874.
60. Moser M. Physician or clinical inertia. What is it? Is it really a problem? And what can be done about it? J Clin Hypertens 2009; 11:1-4.
61. Heron M. Deaths: leading causes for 2006. National Vital Statistics Report. Vol 58, No 14. March 31, 2010.
62. Peterson ED, Gaziano M, Greenland P. Recommendations for treating hypertension: What are the right goals and purposes? JAMA Published online Dec 18, 2013.